Cencora Inc. (COR)
Cencora, Inc. is a pharmaceutical sourcing and distribution company with a focus on providing a wide range of healthcare products and services to various healthcare providers and institutions in the U.S. and internationally.
Company Info
Highlights
$56.47B
$8.65
33.68
0.91
$310.23B
$10.20B
$3.68B
$212.93 - $308.76
$317.09
5.89%
3.24
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Cencora Inc. (COR) returned 29.66% year-to-date (YTD) and 35.00% over the past 12 months. Over the past 10 years, COR delivered an annualized return of 11.43%, outperforming the S&P 500 benchmark at 10.64%.
COR
29.66%
1.54%
18.57%
35.00%
25.11%
27.03%
11.43%
^GSPC (Benchmark)
-0.67%
10.48%
-1.79%
10.08%
13.71%
14.60%
10.64%
Monthly Returns
The table below presents the monthly returns of COR, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 13.14% | -0.04% | 9.68% | 5.24% | -0.68% | 29.66% | |||||||
| 2024 | 13.29% | 1.47% | 3.14% | -1.62% | -5.00% | -0.56% | 5.58% | 0.93% | -6.05% | 1.33% | 10.54% | -10.68% | 10.37% |
| 2023 | 1.96% | -7.65% | 2.92% | 4.21% | 2.27% | 13.09% | -2.87% | -5.60% | 2.27% | 2.88% | 10.13% | 0.99% | 25.33% |
| 2022 | 2.49% | 4.99% | 8.55% | -2.21% | 2.62% | -8.60% | 3.15% | 0.74% | -7.66% | 16.18% | 8.90% | -2.92% | 26.26% |
| 2021 | 6.59% | -2.46% | 16.65% | 2.31% | -4.67% | -0.22% | 6.71% | 0.40% | -2.26% | 2.15% | -4.79% | 14.81% | 38.01% |
| 2020 | 0.64% | -1.02% | 4.96% | 1.31% | 6.87% | 5.70% | -0.58% | -2.76% | -0.11% | -0.88% | 7.77% | -5.19% | 17.03% |
| 2019 | 12.06% | 0.38% | -4.54% | -5.99% | 4.69% | 9.50% | 2.22% | -5.16% | 0.07% | 3.70% | 3.44% | -3.29% | 16.48% |
| 2018 | 8.55% | -4.15% | -9.41% | 5.07% | -8.92% | 3.81% | -4.03% | 10.43% | 2.50% | -4.58% | 1.48% | -16.31% | -17.57% |
| 2017 | 11.63% | 5.27% | -3.29% | -7.29% | 12.32% | 3.01% | -0.75% | -14.07% | 3.12% | -7.01% | 10.75% | 8.25% | 19.51% |
| 2016 | -13.64% | -2.91% | -0.08% | -1.68% | -11.49% | 5.79% | 7.40% | 2.48% | -7.12% | -12.95% | 11.42% | 0.26% | -23.32% |
| 2015 | 5.42% | 8.43% | 10.62% | 0.55% | -1.27% | -5.53% | -0.55% | -5.14% | -5.05% | 1.60% | 2.56% | 5.14% | 16.38% |
| 2014 | -4.39% | 1.29% | -3.33% | -0.63% | 12.67% | -0.71% | 5.85% | 0.94% | -0.12% | 10.49% | 6.95% | -0.98% | 29.95% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 91, COR is among the top 9% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Cencora Inc. (COR) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Cencora Inc. provided a 0.74% dividend yield over the last twelve months, with an annual payout of $2.16 per share. The company has been increasing its dividends for 23 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.16 | $2.08 | $1.97 | $1.87 | $1.78 | $1.70 | $1.60 | $1.54 | $1.48 | $1.39 | $1.21 | $1.00 |
Dividend yield | 0.74% | 0.93% | 0.96% | 1.13% | 1.34% | 1.74% | 1.88% | 2.07% | 1.61% | 1.77% | 1.17% | 1.10% |
Monthly Dividends
The table displays the monthly dividend distributions for Cencora Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $1.10 | |||||||
| 2024 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.55 | $0.00 | $2.08 |
| 2023 | $0.00 | $0.49 | $0.00 | $0.00 | $0.49 | $0.00 | $0.00 | $0.49 | $0.00 | $0.00 | $0.51 | $0.00 | $1.97 |
| 2022 | $0.00 | $0.46 | $0.00 | $0.00 | $0.46 | $0.00 | $0.00 | $0.46 | $0.00 | $0.00 | $0.49 | $0.00 | $1.87 |
| 2021 | $0.00 | $0.44 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.46 | $0.00 | $1.78 |
| 2020 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.44 | $0.00 | $1.70 |
| 2019 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $1.60 |
| 2018 | $0.00 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.40 | $0.00 | $1.54 |
| 2017 | $0.00 | $0.37 | $0.00 | $0.00 | $0.37 | $0.00 | $0.00 | $0.37 | $0.00 | $0.00 | $0.38 | $0.00 | $1.48 |
| 2016 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.37 | $0.00 | $1.39 |
| 2015 | $0.00 | $0.29 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.29 | $0.00 | $0.00 | $0.34 | $0.00 | $1.21 |
| 2014 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.29 | $0.00 | $1.00 |
Dividend Yield & Payout
Dividend Yield
Cencora Inc. has a dividend yield of 0.74%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Cencora Inc. has a payout ratio of 14.57%, which is below the market average. This means Cencora Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Cencora Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Cencora Inc. was 71.01%, occurring on Dec 3, 1999. Recovery took 203 trading sessions.
The current Cencora Inc. drawdown is 4.57%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -71.01% | Jan 22, 1999 | 220 | Dec 3, 1999 | 203 | Sep 22, 2000 | 423 |
| -49.12% | Apr 25, 2007 | 400 | Nov 20, 2008 | 287 | Jan 13, 2010 | 687 |
| -43.09% | Jun 20, 2002 | 185 | Mar 14, 2003 | 697 | Dec 16, 2005 | 882 |
| -40.8% | Jul 28, 1998 | 28 | Sep 3, 1998 | 89 | Jan 12, 1999 | 117 |
| -38.95% | Apr 27, 2015 | 390 | Nov 8, 2016 | 1005 | Nov 5, 2020 | 1395 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Cencora Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Cencora Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 7.9% positive surprise.
Valuation
The Valuation section provides an overview of how Cencora Inc. is priced in the market compared to other companies in the Medical Distribution industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for COR, comparing it with other companies in the Medical Distribution industry. Currently, COR has a P/E ratio of 33.7. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for COR compared to other companies in the Medical Distribution industry. COR currently has a PEG ratio of 0.9. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for COR relative to other companies in the Medical Distribution industry. Currently, COR has a P/S ratio of 0.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for COR in comparison with other companies in the Medical Distribution industry. Currently, COR has a P/B value of 55.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |